Business Description
Scancell Holdings PLC
NAICS : 541711
SIC : 8731
ISIN : GB00B63D3314
Description
Scancell Holdings PLC is engaged in the discovery and development of novel vaccines for the treatment of cancer. The company is exploiting the unrivalled potential of the immune system to seek out and destroy cancer using two proprietary immuno-oncology platforms: ImmunoBody and Moditope. Its potent innovative DNA-based ImmunoBody therapies generate ultra-high avidity T cell responses that target and eliminate cancerous tumors. Its Moditope platform technology overcomes the immune suppression induced by tumors themselves, allowing activated T cells to seek out and kill tumor cells that would otherwise be hidden from the immune system.
Financial Strength
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.66 | |||||
| Equity-to-Asset | -0.38 | |||||
| Debt-to-Equity | -2.37 | |||||
| Debt-to-EBITDA | -1.99 | |||||
| Piotroski F-Score | 3/9 | |||||
| Altman Z-Score | -2.38 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EBITDA Growth Rate | -2.3 | |||||
| 3-Year EPS without NRI Growth Rate | -5.3 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 18.45 | |||||
| 9-Day RSI | 28.71 | |||||
| 14-Day RSI | 33.88 | |||||
| 6-1 Month Momentum % | 4.93 | |||||
| 12-1 Month Momentum % | -37.65 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 8.63 | |||||
| Quick Ratio | 8.63 | |||||
| Cash Ratio | 6.64 | |||||
| Days Sales Outstanding | 41.03 | |||||
| Days Payable | 652.83 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -18.2 | |||||
| Shareholder Yield % | -6.12 |
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 90.04 | |||||
| Operating Margin % | -226.14 | |||||
| Net Margin % | -226.45 | |||||
| FCF Margin % | -201.18 | |||||
| ROE % | -3448.01 | |||||
| ROA % | -31.43 | |||||
| ROIC % | -153.06 | |||||
| ROC (Joel Greenblatt) % | -196.51 | |||||
| ROCE % | -39.16 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 16 | |||||
| EV-to-EBIT | -8.87 | |||||
| EV-to-EBITDA | -9.65 | |||||
| EV-to-Forward-EBITDA | -7.13 | |||||
| EV-to-Revenue | 18.2 | |||||
| EV-to-FCF | -9.05 | |||||
| Earnings Yield (Greenblatt) % | -11.27 | |||||
| FCF Yield % | -11.89 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Scancell Holdings PLC Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil £) | 5.271 | ||
| EPS (TTM) (£) | -0.012 | ||
| Beta | 0.35 | ||
| Volatility % | 39.36 | ||
| 14-Day RSI | 33.88 | ||
| 14-Day ATR (£) | 0.003675 | ||
| 20-Day SMA (£) | 0.1 | ||
| 12-1 Month Momentum % | -37.65 | ||
| 52-Week Range (£) | 0.0931 - 0.172416 | ||
| Shares Outstanding (Mil) | 928.98 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Scancell Holdings PLC Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Scancell Holdings PLC Stock Events
| Event | Date | Price(£) | ||
|---|---|---|---|---|
| No Event Data | ||||
Scancell Holdings PLC Frequently Asked Questions
What is Scancell Holdings PLC(AQSE:SCLP.GB)'s stock price today?
The current price of AQSE:SCLP.GB is £0.10. The 52 week high of AQSE:SCLP.GB is £0.17 and 52 week low is £0.09.
When is next earnings date of Scancell Holdings PLC(AQSE:SCLP.GB)?
The next earnings date of Scancell Holdings PLC(AQSE:SCLP.GB) is 2024-10-24 Est..
Does Scancell Holdings PLC(AQSE:SCLP.GB) pay dividends? If so, how much?
Scancell Holdings PLC(AQSE:SCLP.GB) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers